- Home
- AADI vs CEE Comparison
AADI vs CEE Comparison
Compare AADI & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AADI
- CEE
- Stock Information
- Founded
- AADI 2011
- CEE 1990
- Country
- AADI United States
- CEE Germany
- Employees
- AADI N/A
- CEE N/A
- Industry
- AADI Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- AADI Health Care
- CEE Finance
- Exchange
- AADI Nasdaq
- CEE Nasdaq
- Market Cap
- AADI 77.5M
- CEE 72.9M
- IPO Year
- AADI N/A
- CEE N/A
- Fundamental
- Price
- AADI $2.79
- CEE $13.82
- Analyst Decision
- AADI Hold
- CEE
- Analyst Count
- AADI 3
- CEE 0
- Target Price
- AADI $1.75
- CEE N/A
- AVG Volume (30 Days)
- AADI 114.1K
- CEE 22.0K
- Earning Date
- AADI 03-12-2025
- CEE 01-01-0001
- Dividend Yield
- AADI N/A
- CEE 3.86%
- EPS Growth
- AADI N/A
- CEE N/A
- EPS
- AADI N/A
- CEE N/A
- Revenue
- AADI $25,070,000.00
- CEE N/A
- Revenue This Year
- AADI $8.43
- CEE N/A
- Revenue Next Year
- AADI $5.41
- CEE N/A
- P/E Ratio
- AADI N/A
- CEE N/A
- Revenue Growth
- AADI 7.80
- CEE N/A
- 52 Week Low
- AADI $1.21
- CEE $7.80
- 52 Week High
- AADI $3.81
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- AADI 48.57
- CEE 74.56
- Support Level
- AADI $2.56
- CEE $15.01
- Resistance Level
- AADI $2.94
- CEE $16.71
- Average True Range (ATR)
- AADI 0.13
- CEE 0.70
- MACD
- AADI 0.01
- CEE 0.16
- Stochastic Oscillator
- AADI 57.50
- CEE 66.26
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.